BHC vs. GILD
BHC (Bausch Health Companies Inc.) and GILD (Gilead Sciences, Inc.) are both stocks. Both are in the Healthcare sector — BHC in Drug Manufacturers - Specialty & Generic, GILD in Drug Manufacturers - General. Over the past 10 years, BHC returned -13.37%/yr vs 8.27%/yr for GILD. At a 0.28 correlation, their price movements are largely independent.
Performance
BHC vs. GILD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BHC achieves a -31.51% return, which is significantly lower than GILD's 5.47% return. Over the past 10 years, BHC has underperformed GILD with an annualized return of -13.37%, while GILD has yielded a comparatively higher 8.27% annualized return.
BHC
- 1D
- -9.85%
- 1M
- -11.69%
- YTD
- -31.51%
- 6M
- -33.89%
- 1Y
- -25.74%
- 3Y*
- -13.68%
- 5Y*
- -30.76%
- 10Y*
- -13.37%
GILD
- 1D
- 3.26%
- 1M
- -3.72%
- YTD
- 5.47%
- 6M
- 3.81%
- 1Y
- 21.92%
- 3Y*
- 22.91%
- 5Y*
- 17.72%
- 10Y*
- 8.27%
BHC vs. GILD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BHC Bausch Health Companies Inc. | -31.51% | -13.77% | 0.50% | 27.71% | -77.25% | 32.74% | -30.48% | 61.99% | -11.12% | 43.11% |
GILD Gilead Sciences, Inc. | 5.47% | 36.59% | 18.68% | -1.99% | 23.63% | 29.95% | -6.70% | 7.88% | -9.92% | 2.96% |
Correlation
The correlation between BHC and GILD is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2001 | 0.28 |
The correlation between BHC and GILD shifts across timeframes, from 0.09 (1 year) to 0.28 (all time), reflecting how their relationship changes across market environments.
Fundamentals
BHC:
-$4.32
GILD:
$7.35
BHC:
0.13
GILD:
5.39
BHC:
$10.55B
GILD:
$29.74B
BHC:
$7.97B
GILD:
$18.74B
BHC:
$1.41B
GILD:
$12.88B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BHC vs. GILD — Risk / Return Rank
BHC
GILD
BHC vs. GILD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bausch Health Companies Inc. (BHC) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BHC | GILD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.35 | ||
| Sortino ratioReturn per unit of downside risk | -1.93 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 1.16 | -0.22 |
| Calmar ratioReturn relative to maximum drawdown | -0.59 | 1.02 | -1.61 |
| Martin ratioReturn relative to average drawdown | -0.99 | 2.63 | -3.62 |
Loading charts...
Drawdowns
BHC vs. GILD - Drawdown Comparison
The maximum BHC drawdown since its inception was -98.35%, which is greater than GILD's maximum drawdown of -70.83%. Use the drawdown chart below to compare losses from any high point for BHC and GILD.
Loading charts...
Drawdown Indicators
| BHC | GILD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.35% | -70.83% | -27.52% |
Max Drawdown (1Y)Largest decline over 1 year | -44.00% | -21.59% | -22.41% |
Max Drawdown (3Y)Largest decline over 3 years | -59.28% | -26.59% | -32.69% |
Max Drawdown (5Y)Largest decline over 5 years | -85.63% | -26.59% | -59.04% |
Max Drawdown (10Y)Largest decline over 10 years | -87.43% | -30.47% | -56.96% |
Current DrawdownCurrent decline from peak | -98.19% | -16.91% | -81.28% |
Average DrawdownAverage peak-to-trough decline | -60.95% | -22.15% | -38.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.10% | 8.36% | +17.74% |
Volatility
BHC vs. GILD - Volatility Comparison
Bausch Health Companies Inc. (BHC) has a higher volatility of 17.35% compared to Gilead Sciences, Inc. (GILD) at 8.53%. This indicates that BHC's price experiences larger fluctuations and is considered to be riskier than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BHC | GILD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.35% | 8.53% | +8.82% |
Volatility (6M)Calculated over the trailing 6-month period | 31.33% | 19.09% | +12.24% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.58% | 26.61% | +22.97% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 60.82% | 24.20% | +36.62% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 59.81% | 25.52% | +34.29% |
Dividends
BHC vs. GILD - Dividend Comparison
BHC has not paid dividends to shareholders, while GILD's dividend yield for the trailing twelve months is around 2.52%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BHC Bausch Health Companies Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GILD Gilead Sciences, Inc. | 2.52% | 2.57% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% |
Financials
BHC vs. GILD - Financials Comparison
This section allows you to compare key financial metrics between Bausch Health Companies Inc. and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BHC vs. GILD - Profitability Comparison
BHC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bausch Health Companies Inc. reported a gross profit of 2.48B and revenue of 2.50B. Therefore, the gross margin over that period was 99.3%.
GILD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Gilead Sciences, Inc. reported a gross profit of 79.20M and revenue of 6.96B. Therefore, the gross margin over that period was 1.1%.
BHC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bausch Health Companies Inc. reported an operating income of -950.00M and revenue of 2.50B, resulting in an operating margin of -38.0%.
GILD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Gilead Sciences, Inc. reported an operating income of 2.59B and revenue of 6.96B, resulting in an operating margin of 37.2%.
BHC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bausch Health Companies Inc. reported a net income of -1.42B and revenue of 2.50B, resulting in a net margin of -56.9%.
GILD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Gilead Sciences, Inc. reported a net income of 2.02B and revenue of 6.96B, resulting in a net margin of 29.0%.
Frequently Asked Questions
BHC and GILD have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BHC has higher volatility (17.35%) compared to GILD (8.53%). In terms of maximum drawdown, BHC dropped -98.35% vs GILD's -70.83%.
GILD currently has the higher Sharpe Ratio (0.83 vs -0.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BHC and GILD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer